NIH awards $5 million grant for stem cell therapy

06/2/2009 | Salt Lake Tribune (Utah), The

The NIH awarded Q Therapeutics a $5 million grant to work on securing FDA clearance to conduct human clinical trials of Q-cells, a stem cell therapy that can treat paralysis and other neurodegenerative illnesses such as Parkinson's disease and amyotrophic lateral sclerosis. The company is working with the University of Utah's Cell Therapy Facility and the Johns Hopkins University School of Medicine to further investigate the drug.

View Full Article in:

Salt Lake Tribune (Utah), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ